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19th CardioVascular Summit: TCTAP 201419% of the cases had Mid LAD stenosis, 25% had Left Circumﬂex Artery (LCX)
stenosis and 22% had Right Coronary Artery (RCA) proximal stenosis. 74% of the
patients had 3mm diameter stents, 20% had 2.75mm and 6% had 2.5mm. The length
varied from 12 mm to 28 mm. The mean follow up was for 2 years. Four patients
(5.3%) had symptoms suggestive of restenosis out of which one patient (1.3%) died
within 6 weeks duration due to drug default. The remaining 3 patients (4 %) had
symptoms suggestive of restenosis became better with optimization of drugs. None of
them required restudy or repeat revascularization during follow up. Repeat angiogram
couldn’t be done due to ﬁnancial constrains. All other patients were asymptomatic.
Conclusion: The safety proﬁle of BMS is not as inferior as it is thought. Most of the
PCI with BMS were done for Proximal LAD stenosis. The Stent size, proper deploy-
ment, adherence to drugs, modiﬁcation of risk factors reduces the chance of restenosis
in BMS. This study emphasis that BMS is as still a good choice in Rural Health Care
centers in India where there are ﬁnancial constrains and no uniform insurance policy.
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Background: Coronary artery spasm (CAS) is known to be a major cause of
myocardial ischemia. Multi-vessel spasm (MVS) is likely to induce more severe and
prolonged myocardial ischemia than single vessel spasm (SVS). The aim of this study
is to evaluate the impact of MVS vs. SVS as assessed by the intracoronary acetyl-
choline (Ach) provocation test on 3 years clinical outcomes.
Methods: A total of 2,998 consecutive patients (pts) without signiﬁcant coronary
artery disease who underwent an acetylcholine (Ach) provocation test from Nov 2004
to Oct 2010 were enrolled. Among them, a total of 1,609 pts were ﬁnally diagnosed as
Ach positive test and were divided into two groups; MVS group (n¼555pts) and SVS
group (n¼1054 pts). To adjust potential confounders, propensity score matched
(PSM) analysis was performed using the logistic regression model (C-statics: 0.81).
After PSM, total of 1,068 pts (534 pairs) were enrolled for this analysis.
Results: After PSM, the baseline characteristics were balanced between the two
groups. During the ACh test, the response rate to lower ACh doses that induce CAS
was higher in MVS group. However, there were no difference of cumulative clinical
outcomes including mortality, de Novo percutaneous coronary intervention (PCI),
cerebrovascular disease (CVD), and repeated coronary artery angiography (CAG) due
to recurrent chest pain up to 3 years (Table 1). Multivariate analysis showed that MVS
was not a predictor of repeated CAG due to recurrent chest pain (OR:1.4, 95% CI: 0.9-
2.2, p-value¼0.189) and major adverse cardiac and cerebrovascular events (MACCE)
including mortality, PCI, CVD, and repeated CAG due to recurrent chest pain
(OR:1.3, 95% CI: 0.2-6.0, p-value¼0.705).
Conclusion: MVS was associated with higher response rate to lower Ach doses,
showing more vulnerable spastic response. However, MVS was not a predictor of
repeated CAG due to recurrent chest pain and MACE as compared with SVS.TCTAP A-196
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Background: High dose atrovastatin is known to be associated with new onset dia-
betes mellitus (DM) in patients (pts). We investigated the impact of low dose (10mg or
20mg) atorvastatin on the development of new-onset DM based on ﬁve-year clinical
outcomes in Asian patients.S56 JACC Vol 63/12/Suppl S jMethods:We investigated a total of 3,566 consecutive patients (pts) who did not have
DM from January 2004 to September 2009. To adjust potential confounders, a pro-
pensity score matched (PSM) analysis was performed using the logistic regression
model. The primary end-point was the cumulative incidence of new-onset DM which
was deﬁned as having a fasting blood glucose 126 or HbA1c 6.5%. and assessed
to determine the impact of low dose atrovastatin (10mg or 20mg).
Results: Mean follow-up duration was 976278 days in all-pt group, and 993240
days in PSM group. After PSM (C-statistics: 0.851), a total 818 pts were enrolled for
analysis. Adjusted with cox-regression analysis showed that low dose atorvastatin was
an independent predictor of new-onset DM (OR¼1.99, 95%CI 1.00– 3.98, p¼0.050,
ﬁgure A). After PSM analysis, total 98 pts (atorvastatin 10mg, 49 and 20mg, 40) were
analyzed (C-statistics: 0.715). There was no difference in the cumulative incidence of
new-onset DM between the two groups (ﬁgure B).
Conclusion: Low dose atorvastatin therapy was associated with the cumulative
incidence of new-onset DM, however, there was no difference between atrovastatin
10mg and 20mg in Asian population.TCTAP A-197
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Background: Coronary artery calcium scoring (CACS) has been known to be a
predictor of cardiovascular events. However, there is very little information regarding
the relationship among laboratory biomarkers, echocardiographic parameters, and
CACS.
Methods: We investigated clinical characteristics, laboratory biomarkers and echo-
cardiographic parameters of the 1230 patients (pts) underwent echocardiography
and 64-channel multidetector compute tomography (MDCT) from 2007 to
2011. CACS was measured by Agatston score. Biomarker and echocardiographic
parameters were compared between the CACS¼0 group (n¼428) and CACS>0 group
(n¼802).
Results: Diabetes mellitus, hypertension, and hs-CRP>2.0 mg/dl were more frequent
in CACS>0 group. Uric acid, hs-CRP, LVMI, and E/E’ were higher, whereas he-
moglobin, eGFR, calcium, phosphate, LVEF, and HDL-cholesterol were lower in
CACS>0 group as compared with CACS¼0 group. In multivariate analysis adjusted
by gender, age, diabetes, hypertension, smoking history, and GFR, we found that
HDL-cholesterol level was lower in the CACS>0 group, whereas LVMI, and E/E’
were higher in the CACS>0 group (table).
Conclusion: In our study, we found lower HDL-cholesterol, higher LVMI and E/E’
were associated with CACS.April 22–25, 2014 j TCTAP Abstracts/POSTER/Other (Unclassiﬁed)
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Elevated Plasma HsCRP Level Is a Predictor of Periprocedural Myocardial
Injury During PCI
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National Institute of Cardiovascular Disease, Dhaka, Bangladesh
Background: Elevated high sensitivity C-reactive protein (hs-CRP) has been well
known as a biomarker reﬂecting inﬂammatory process for prediction of ischemic
events among patients with coronary artery disease. Relatively small studies have
identiﬁed a heightened and sustained inﬂammatory response after PCI to be a pre-
dictor of periprocedural events after coronary angioplasty and a marker of increased
restenosis risk among patients undergoing coronary stenting. Embolization of
atherosclerotic and thrombotic debris can induce myocardial necrosis during percu-
taneous coronary interventions (PCIs). This study was designed to evaluate whether
pre procedural hs-CRP level is associated with procedure related distal micro-
embolization producing myocardial injury (assessed by CK-MB level) after percuta-
neous coronary intervention (PCI).
Methods: A total of 310 patients with chronic stable angina and acute coronary
syndrome, who would undergo elective percutaneous coronary intervention were
evaluated in National Institute of Cardiovascular Disease (NICVD), Dhaka with a
view to evaluate the relationship between preprocedural hs-CRP and rise of CK-MB
level, before and after PCI. Patients were divided in 2 groups according to hs-CRP:
Group I ¼ hs-CRP < 3 mg/ L, Group II ¼ hs-CRP > 3 mg/ L.
Results: A total of 310 who were divided into two groups: Normal CRP group (n ¼
131) and elevated CRP group (n¼ 179). Following PCI, CK-MB level was raised
from baseline in both groups. In normal CRP group, there was no signiﬁcant elevation
of CK-MB level after PCI (Pre-procedural VS Post-procedural: 18.6  5.4 VS 29.1 
5.6 mg/L, p¼ ns). In elevated CRP group, there was signiﬁcant elevation of CK-MB
level after PCI (Pre-procedural VS Post-procedural: 19.1  6.7 VS 52.46  9.4 mg/L,
p < 0.01). The mean rise of CK-MB level was higher in group II than group I
(33.0611.62U/L vs. 11.529.60 U/L). The ﬁndings were statistically signiﬁcant
between the study groups (p>0.05). Also there was a positive linear correlation be-
tween preprocediral hsCRP level and rise of CKMB (r¼0.22) following procedure and
it was statistically signiﬁcant (p<0.05). Multivariate logistic regression analysis done
among traditional predictors of PCI outcome advanced age (>50 years), female
gender, diabetes mellitus, BMI, hypertension, smoking, dylipidaemia, Type C lesion,
multiple stents, post dilatation and hsCRP. After removing the effects of the all other
variables, hs- CRP was independent predictors of periprocedural myocardial injury
during PCI, assessed by CK-MB elevation with OR 1.57 and p¼0.001.
Conclusion: The inﬂammatory activity, as represented by hs-CRP level, is associated
with procedure related microvascular injury as assessed by CK-MB elevation after
PCI. Measurement of hs-CRP levels could provide a rationale for risk stratiﬁcation
before coronary intervention and may be a useful tool to target aggressive anti-
aggregatory or anti-inﬂammatory therapy to patients that are exposed to the highest
risk for ischemic complications. As distal microembolization is a determinant of short
and long term mortality after PCI, speciﬁc strategies may be developed to minimize
myocardial injury in subjects with elevated hs-CRP level.
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Interaction Between Renin-angiotensin-aldosterone System Genes and Serum
Uric Acid on Blood Pressure
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Background: Hemodynamic changes in central aorta were independently associated
with target organ damage and cardiovascular diseases. Central blood pressure (BP)
may be more predictive than brachial BP. Understanding the interaction betweenJACC Vol 63/12/Suppl S j April 22–25, 2014 j TCTAP Abstracts/POSTgenetic and environmental factors contributing to BP is an important issue in view of
the relation of hypertension with outcome. Genetic variation of renin-angiotensin-
aldosterone system (RAAS) genes is closely related to the susceptibility in hyper-
tension, and plays an important role in the changing of artery structure and function in
hypertensives. Moreover, because the pathophysiological role of central aortic and
brachial BP is different, genetic variations maybe have different effects on the regu-
lation of central and brachial BP. Using the standardized genetic epidemiological
methods in the general population, we studied the association of two single nucleotide
polymorphisms (SNPs) in RAAS genes including angiotensin II type 2 receptor
(AT2R, G1675A polymorphism), angiotensinogen (AGT, C-532T polymorphism)
with central and brachial BP and hypertension. We also studied the interaction be-
tween genes and environmental factors, in relation to central BP, brachial BP and
hypertension.
Methods: In 1293 residents of Zhejiang province, we conducted a questionnaire
survey, collected blood, estimated central blood pressure using the SphygmoCor de-
vice and genotyped two SNPs in candidate RAAS genes with polymerase chain re-
action-restriction fragment length polymorphism (PCR-RFLP) method and Taqman
probe method. SAS 9.1 software was used for statistical analysis.
Results: The 1293 participants included 308 (23.8%) hypertensive patients, of whom
106 (34.4%) were taking antihypertensive medication. For AGT C-532T poly-
morphism, CT and TT compared with CC had lower central pulse pressure (PP)
(P¼0.048) in all subjects and lower central SBP (P¼0.03) and PP (P¼0.02) in men.
Each T allele was associated with a lower central PP by 2.5mmHg. We found a
signiﬁcant interaction between AGT C-532T polymorphism and AT2R G1675A
polymorphism in relation to central SBP (Pint¼0.05). With the increase of the AGT
C-532T T allele, the A allele carriers of the AT2R G1675A polymorphism had a lower
central SBP (P¼0.05). We also found a signiﬁcant interaction between the AGT
C-532T polymorphism and serum uric acid in relation to central BP (Pint0.03).
Compared with AGT C-532T CC subjects central BP was signiﬁcantly lower in
T allele carriers with a concentration of serum uric acid between 264mmol/l and
319mmol/l (P0.04).
Conclusion: First, both in single gene analysis and analyses involving gene-gene,
gene-environment interactions, the T allele carriers of AGT C-532T polymorphism
(except women) showed a lower central SBP and PP. AGT C-532T polymorphism
may be associated with hypertension and arterial stiffness. Second, the interaction
between AGT C-532T polymorphism and AT2R G1675A polymorphism inﬂuenced
central SBP. With the increase of the AGT C-532T T allele, the A allele carriers of the
AT2R G1675A polymorphism had a lower central SBP compared with GG homo-
zygotes. The AT2R G1675A polymorphism may be involved in the blood pressure
regulation. Genetic variants of RAAS might interact with environmental factors in the
regulation of central BP, pathogenesis of hypertension and arterial stiffness.
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Background: There are limited data how whether there are differences in clinical
outcomes according to spasm extent (focal versus diffuse) and spasm type (single
versus multi-vessel).
Methods: A total 2812 patients (pts) underwent coronary angiography with acetyl-
choline (Ach) provocation test from Nov 2004 to Oct 2010 from prospective spasm
registry were enrolled. The pts were categorized into three groups; negative spasm test
group (n¼1178), other positive group (n¼1098), diffuse and multivessel spasm group
(n¼536). The deﬁnition of diffuse spasm was deﬁned as longer than 30mm in length
of signiﬁcant spasm area. Other positive spasm group consisted of total positive Ach
provocation test groups except diffuse and multi-vessel spasm group. Cumulative
clinical outcomes up to 3 years were compared among the 3 groups.
Results: In proportional hazard Cox-regression analysis adjusted by co-variates such
as age, gender, current smoking, current alcoholics, myocardial bridge, HDL
cholesterol, hypertension, diabetes, and dyslipidemia, diffuse and multivessel spasm
group had the higher incidence of recurrent chest pain requiring repeat coronary
angiography during 3-year follow-up, compared to other positive spasm group (HR,
0.634; 95% CI, 0.431-0.931; p-value, 0.020) and negative spasm group (HR, 0.505;
95% CI, 0.336-0.758; p-value, <0.001). However, there was no difference between
other positive spasm group and negative spasm group (Figure).
Conclusion: The pts with diffuse and multivessel spasm was associated with higher
incidence of adverse clinical outcomes such as recurrent chest during 3-year follow-up
period.ER/Other (Unclassiﬁed) S57
